This is the main conclusion of a large American study just published in Biology of Sex Differences, which analyzed literature data from more than 5,400 references to determine whether gender differences in pharmacokinetic parameters predict differences in the occurrence of adverse events in men and [...]
Test a cardiovascular screening tool for 50-year-old women on a panel of 1,000 women for three years. This project is supported by the Agence Régionale de Santé des Hauts de France, in partnership with the Union Régionale des Professionnels de Santé Libéraux, Associations de Cardiologie Nord [...]
Agir pour le Cœur des Femmes is driven by a single ambition: to reduce cardiovascular disease in France. To achieve this, our priority actions aim to save the lives of 100,000 women by 2030: - The development of care paths structured around women's health, with multidisciplinary care involving [...]